Delivery Order SPE2DP20D0002-SPE2DP25F4431
Award Date
3/6/25
Potential Completion Date
3/25/25
Potential Value
$661K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $660,627.72, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. This is an unrestricted contract, meaning Teva competed as a large business without any set-aside designations. Teva Pharmaceuticals USA, Inc. also holds...
This federal contract award, valued at $1,588,047.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 A vaccine, a critical product for military immunization programs. The delivery order contract is firm-fixed-price with a period of performance through April 30, 2024. While the original solicitation is not provided, this award is...
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. Teva Pharmaceuticals USA, Inc. has a history of providing critical drug products, such as vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $1,111,633.11 firm-fixed-price delivery order is for the supply of Adenovirus Type 4 vaccine, a critical product used in military immunization programs. This award falls under a larger $5.7 million Indefinite Delivery Contract (IDC) that establishes Teva as the national prime vendor to provide...
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a large, foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. has a long history of supplying...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $165,156.93, is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. has received numerous federal contract awards from the DLA for the supply of critical pharmaceutical products, including...
The U.S. Defense Logistics Agency (DLA) awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $317,609.46 Delivery Order contract for the supply of Adenovirus Type 4 vaccines. This order falls under DLA Troop Support Medical's larger portfolio of contracts supporting military immunization programs. The contract has a firm fixed-price, with a completion date of June 25, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drugs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of Adenovirus Type 4 vaccine, a critical product for military immunization programs. The $158,804.73 firm-fixed-price contract has a period of performance through March 26, 2024. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts and delivery orders from...
This federal contract award, valued at $990,941.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order for the supply of Adenovirus Type 4 vaccine, a critical medical product that supports military immunization programs. The contract is a firm-fixed-price arrangement with a period of performance through March 25, 2025. Teva Pharmaceuticals USA, Inc....
This federal contract award to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, provides the Adenovirus Type 4 vaccine to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,111,633.11 firm fixed-price delivery order (SPE2DP24F7165) has an ultimate completion date of August 27, 2024. This contract is not set aside and is part of Teva's larger role as a prime vendor supplying critical pharmaceutical products to various federal agencies, including the...